Cormorant Asset Management »

Y Mabs Therapeutics shares owned by Cormorant Asset Management

Quarter-by-quarter ownership of Y Mabs Therapeutics (YMAB) shares owned by Cormorant Asset Management from 13F filings

Historical chart of Cormorant Asset Management investment in Y Mabs Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Y Mabs Therapeutics held by Cormorant Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Y Mabs Therapeutics by Cormorant Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $3.3M 425k 7.83
2024-09-30 $19M 1.5M 13.15
2024-06-30 $18M 1.5M 12.08
2022-12-31 $732k 150k 4.88
2022-09-30 $2.2M 150k 14.42
2022-06-30 $2.3M 150k 15.13
2022-03-31 $1.8M 150k 11.88
2021-12-31 $4.9M 300k 16.21
2021-09-30 $14M 500k 28.54
2021-06-30 $27M 800k 33.80
2021-03-31 $37M 1.2M 30.24
2020-12-31 $82M 1.7M 49.51
2020-09-30 $54M 1.4M 38.39
2020-06-30 $68M 1.6M 43.20
2020-03-31 $45M 1.7M 26.10
2019-12-31 $50M 1.6M 31.25
2019-09-30 $23M 884k 26.06
2019-06-30 $23M 1.0M 22.87
2019-03-31 $19M 716k 26.21
2018-12-31 $4.0M 195k 20.34
2018-09-30 $5.3M 200k 26.56